PCASE1 ESTABLISHMENT OF A COST-EFFECTIVENESS (CE) THRESHOLD AT KING HUSSEIN CANCER CENTER- IMATINIB IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)67137-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)67137-9/fulltext
Title :
PCASE1 ESTABLISHMENT OF A COST-EFFECTIVENESS (CE) THRESHOLD AT KING HUSSEIN CANCER CENTER- IMATINIB IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67137-9&doi=10.1016/S1098-3015(10)67137-9
First page :
Section Title :
Open access? :
No
Section Order :
972